From: French recommendations for the management of systemic sclerosis
Domain | Criteria* | Score# |
---|---|---|
Cutaneous thickening (only consider the highest score) | Cutaneous thickening of the fingers extending beyond the MCP joints | 9 |
Swollen fingers | 2 | |
Symptoms of the fingers not extending beyond the MCP joints | 4 | |
Pulp lesions (only consider the highest score) | Digital pulp ulcers | 2 |
Depressed scars | 3 | |
Telangiectasias | Â | 2 |
Capillaroscopic anomalies | Â | 2 |
Pulmonary damage | PAH and/or pulmonary fibrosis | 2 |
Raynaud’s phenomenon |  | 3 |
SSc-specific antibodies | Anti-topoisomerase I | 3 |
Anticentromere antibodies | ||
Anti-RNA polymerase III |